Aimmune Therapeutics logo

Aimmune Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

Aimmune Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for potentially life-threatening food allergies. Its Characterized Oral Desensitization ImmunoTherapy (CODIT) approach desensitizes patients with defined, precise amounts of key allergens to reduce reactions from accidental exposure. The company currently has one FDA-approved medicine for peanut allergy and is pursuing additional therapies for other food allergies. Headquartered in Brisbane, California, in the San Francisco Bay Area's biotech hub, Aimmune maintains offices in Durham, North Carolina; the Paddington area of London; Dublin, Ireland; and Munich, Germany, and is part of Nestlé Health Science.

Find Aimmune Therapeutics employees' phone numbers or email addresses

Aimmune Therapeutics Global Highlights

Location
Employees

North America
152

Minus sign iconPlus sign icon
  • United States Of America
    151
  • Canada
    1

Europe
14

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    9
  • Switzerland
    4
  • France
    1

Asia
2

Minus sign iconPlus sign icon
  • Indonesia
    1
  • India
    1

Aimmune Therapeutics's Leadership

  • Chief Financial Officer at Aimmune Therapeutics
    E. B.
    Chief Financial Officer
  • Vice President Investor Relations at Aimmune Therapeutics
    L. H.
    Vice President Investor Relations
  • Vice President Market Access And Pricing at Aimmune Therapeutics
    M. F.
    Vice President Market Access And Pricing
  • Vice President Clinical Development at Aimmune Therapeutics
    S. M.
    Vice President Clinical Development
  • President at Aimmune Therapeutics
    P. O.
    President
  • Head Of Clinical Operations Eu, Senior Director, Aimmune Therapeutics at Aimmune Therapeutics
    M. C.
    Head Of Clinical Operations Eu, Senior Director, Aimmune Therapeutics
  • Head Of Strategy And Business Transformation at Aimmune Therapeutics
    H. L.
    Head Of Strategy And Business Transformation
  • Ea To Chief Medical Officer, Senior Vice President Regulatory Affairs And Svp, Global Head Medical Affairs at Aimmune Therapeutics
    Y. A.
    Ea To Chief Medical Officer, Senior Vice President Regulatory Affairs And Svp, Global Head Medical Affairs

Aimmune Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Customer Success
  • Sales
  • Quality Assurance
  • Operations
  • Accounting
  • Other
  • Consultant
  • Research
  • Engineering
  • Administrative
  • Biotechnology
  • Legal
  • Branding

Contact profiles from Aimmune Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Financial Officer at Aimmune Therapeutics
    E. B.
    Chief Financial Officer
    Oct 23, 2024
  • President at Aimmune Therapeutics
    P. O.
    President
    Oct 17, 2024
  • Ea To Chief Medical Officer, Senior Vice President Regulatory Affairs And Svp, Global Head Medical Affairs at Aimmune Therapeutics
    Y. A.
    Ea To Chief Medical Officer, Senior Vice President Regulatory Affairs And Svp, Global Head Medical Affairs
    Oct 23, 2024
  • Regional Head, Area 1, International at Aimmune Therapeutics
    A. O.
    Regional Head, Area 1, International
    Switzerland, Vaud
    Jun 02, 2026
  • Head Of Clinical Operations Eu, Senior Director, Aimmune Therapeutics at Aimmune Therapeutics
    M. C.
    Head Of Clinical Operations Eu, Senior Director, Aimmune Therapeutics
    United Kingdom
    Aug 13, 2026
  • Head Of Strategy And Business Transformation at Aimmune Therapeutics
    H. L.
    Head Of Strategy And Business Transformation
    Oct 23, 2024
  • Vice President Investor Relations at Aimmune Therapeutics
    L. H.
    Vice President Investor Relations
    Oct 22, 2024
  • Vice President Market Access And Pricing at Aimmune Therapeutics
    M. F.
    Vice President Market Access And Pricing
    Oct 23, 2024
  • Vice President Clinical Development at Aimmune Therapeutics
    S. M.
    Vice President Clinical Development
    Oct 17, 2024
  • Associate Director Of Information Technology at Aimmune Therapeutics
    S. K. S.
    Associate Director Of Information Technology
    Bay
    Sep 05, 2026

Frequently Asked Questions

What is Aimmune Therapeutics known for?

Minus sign iconPlus sign icon
Aimmune Therapeutics was founded in 2011 and operates in the Biotechnology Research industry. You can contact Aimmune Therapeutics's main corporate office by phone at . Explore Aimmune Therapeutics's company overview page for more information.

What is Aimmune Therapeutics's most common email format?

Minus sign iconPlus sign icon
Aimmune Therapeutics employees' email format typically follows the pattern of FLast@aimmune.com. Trying to find reliable and up-to-date employee contact data? Find more Aimmune Therapeutics email formats with LeadIQ.

How many employees does Aimmune Therapeutics have currently?

Minus sign iconPlus sign icon
Aimmune Therapeutics has approximately 67 employees as of August 2026. These team members are located across 3 continents, including North America, Europe and Asia.

Who are Aimmune Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Aimmune Therapeutics's key employees include:

  • Chief Financial Officer: E. B.
  • Vice President Investor Relations: L. H.
  • Vice President Market Access And Pricing: M. F.
  • Vice President Clinical Development: S. M.
  • President: P. O.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.